Manuel Besendörfer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Manuel Besendörfer has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sonja Diez
Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Department of Pediatric Surgery, University Hospital Erlangen, Erlangen, Germany
4 shared publications - Arndt Hartmann
Institute of Pathology University Hospital Erlangen, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Erlangen Germany
2 shared publications - Christel Weiss
Institute of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
2 shared publications - Hanna Müller
Neonatology and Pediatric Intensive Care, Department of Pediatrics, University of Marburg, Marburg, Germany
2 shared publications - Julia Moosmann
Department of Congenital Heart Disease—Pediatric Cardiology, Deutsches Herzzentrum der Charité—Medical Heart Center of Charité, Augustenburger Platz 1, 13353 Berlin, Germany
2 shared publications - Marcus Renner
Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany
2 shared publications
Latest Publications
- Open Access
- 24 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (4) , 1275-1279
Case report of successful management of open abdomen due to abdominal compartment syndrome in a patient with neuroblastoma stage 4S using the Fasciotens Pediatric® System
Introduction and importance: Abdominal compartment syndrome (ACS) due to metastatic hepatomegaly is a rare condition in pediatric patients. While decompressive laparotomy remains the treatment of choice for ACS, long-term stabilization of critically ill patients with an open abdomen, as well as secondary closure of the abdominal wall remains challenging regarding further oncological treatment. Presentation of case: We present a 2.5-month-old female infant with neuroblastoma stage 4S and ACS due to hepatic metastases and massive hepatomegaly. The patient achieved stabilization after several surgeries via open abdomen therapy. Gradual expansion of the abdominal wall in preparation for secondary abdominal wall closure was achieved using a Gore-Tex® patch in combination with the Fasciotens Pediatric® System. Clinical discussion: Intensive interdisciplinary care is essential for the management of infants with ACS resulting from metastatic hepatomegaly. While the stabilization of these patients already poses a significant challenge, additional difficulties arise from the need to continue oncological treatment, as well as the complex considerations surrounding abdominal wall closure. Conclusion: This case demonstrates that vertical traction using the Fasciotens Pediatric® system may support safe open abdomen management in infants with ACS due to metastatic neuroblastoma and can facilitate subsequent continuation of oncological therapy.
- 24 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (4) , 1275-1279
Open AccessCase report of successful management of open abdomen due to abdominal compartment syndrome in a patient with neuroblastoma stage 4S using the Fasciotens Pediatric® System
Introduction and importance: Abdominal compartment syndrome (ACS) due to metastatic hepatomegaly is a rare condition in pediatric patients. While decompressive laparotomy remains the treatment of choice for ACS, long-term stabilization of critically ill patients with an open abdomen, as well as secondary closure of the abdominal wall remains challenging regarding further oncological treatment. Presentation of case: We present a 2.5-month-old female infant with neuroblastoma stage 4S and ACS due to hepatic metastases and massive hepatomegaly. The patient achieved stabilization after several surgeries via open abdomen therapy. Gradual expansion of the abdominal wall in preparation for secondary abdominal wall closure was achieved using a Gore-Tex® patch in combination with the Fasciotens Pediatric® System. Clinical discussion: Intensive interdisciplinary care is essential for the management of infants with ACS resulting from metastatic hepatomegaly. While the stabilization of these patients already poses a significant challenge, additional difficulties arise from the need to continue oncological treatment, as well as the complex considerations surrounding abdominal wall closure. Conclusion: This case demonstrates that vertical traction using the Fasciotens Pediatric® system may support safe open abdomen management in infants with ACS due to metastatic neuroblastoma and can facilitate subsequent continuation of oncological therapy.
- Open Access
Prediction of High Bell Stages of Necrotizing Enterocolitis Using a Mathematic Formula for Risk Determination
Necrotizing enterocolitis (NEC) continues to cause high morbidity and mortality. Identifying early predictors for severe NEC is essential to improve therapy and optimize timing for surgical intervention. We present a retrospective study of patients with NEC, treated between 2010 and 2020, trying to identify factors influencing the severity of NEC. Within the study period, 88 affected infants with NEC or NEC-like symptoms are analyzed. A multiple logistic regression analysis reveals the following three independent predictors for NEC in Bell stage III: red blood cell transfusion (p = 0.027 with odds ratio (OR) = 3.298), sonographic findings (p = 0.037; OR = 6.496 for patients with positive vs. patients without pathological findings) and cardiac anatomy (p = 0.015; OR = 1.922 for patients with patent ductus arteriosus (PDA) vs. patients with congenital heart disease (CHD); OR = 5.478/OR = 2.850 for patients with CHD/PDA vs. patients without cardiac disease). Results are summarized in a clinical score for daily application in clinical routine. The score is easy to apply and combines clinically established parameters, helping to determine the timing of surgical intervention.
Open AccessPrediction of High Bell Stages of Necrotizing Enterocolitis Using a Mathematic Formula for Risk Determination
Necrotizing enterocolitis (NEC) continues to cause high morbidity and mortality. Identifying early predictors for severe NEC is essential to improve therapy and optimize timing for surgical intervention. We present a retrospective study of patients with NEC, treated between 2010 and 2020, trying to identify factors influencing the severity of NEC. Within the study period, 88 affected infants with NEC or NEC-like symptoms are analyzed. A multiple logistic regression analysis reveals the following three independent predictors for NEC in Bell stage III: red blood cell transfusion (p = 0.027 with odds ratio (OR) = 3.298), sonographic findings (p = 0.037; OR = 6.496 for patients with positive vs. patients without pathological findings) and cardiac anatomy (p = 0.015; OR = 1.922 for patients with patent ductus arteriosus (PDA) vs. patients with congenital heart disease (CHD); OR = 5.478/OR = 2.850 for patients with CHD/PDA vs. patients without cardiac disease). Results are summarized in a clinical score for daily application in clinical routine. The score is easy to apply and combines clinically established parameters, helping to determine the timing of surgical intervention.
- Open Access
- 11 April 2022
- Published by Springer Nature in BMC Pediatrics
- Vol. 22 (1) , 1-9
Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study
In neonatal patients with necrotizing enterocolitis (NEC) the inflammatory response is mediated by a plurality of different proteins. The proteins olfactomedin 4 (OLFM4) and lysozyme (LYZ) are part of the intestinal mucosal defense and especially OLFM4 has rarely been evaluated in neonatal gastrointestinal diseases. The aim of this study was to analyze whether expression levels of both proteins of innate immunity, OLFM4 and lysozyme, were increased during NEC in neonates. Intestinal tissues of patients with NEC were examined with immunohistochemical staining of formalin-fixed and paraffin-embedded sections of resected tissue using antibodies against OLFM4 and lysozyme. Staining-positive tissues were semi-quantitatively scored from 0 (no staining), 1 (weak staining), 2 (moderate staining) to 3 (highly intense staining) by two individual investigators. Intestinal tissue of infants with volvulus was used as a control as other intestinal tissue without major inflammation was not available. Both applied antibodies against OLFM4 showed different staining patterns with higher staining intensity of the antibody OLFM4 (D1E4M). OLFM4 (median score of the antibody OLFM4 (D1E4M): 3.0) and lysozyme (median score: 3.0) are highly expressed in intestinal and immune cells during NEC. Expression of OLFM4 and lysozyme in the control samples with volvulus was observable but significantly lower (median score of the antibody OLFM4 (D1E4M): 1.25; median score of the antibody against LYZ: 2.0; p = 0.033 and p = 0.037, respectively). Both proteins, OLFM4 and lysozyme, may play a role in the pathogenesis of NEC in neonatal patients, but the exact mechanisms of OLFM4 and lysozyme function and their role in immunological responses have not yet been resolved in detail. These observations add new insights as basis for further large-scale population research.
- 11 April 2022
- Published by Springer Nature in BMC Pediatrics
- Vol. 22 (1) , 1-9
Open AccessIncreased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study
In neonatal patients with necrotizing enterocolitis (NEC) the inflammatory response is mediated by a plurality of different proteins. The proteins olfactomedin 4 (OLFM4) and lysozyme (LYZ) are part of the intestinal mucosal defense and especially OLFM4 has rarely been evaluated in neonatal gastrointestinal diseases. The aim of this study was to analyze whether expression levels of both proteins of innate immunity, OLFM4 and lysozyme, were increased during NEC in neonates. Intestinal tissues of patients with NEC were examined with immunohistochemical staining of formalin-fixed and paraffin-embedded sections of resected tissue using antibodies against OLFM4 and lysozyme. Staining-positive tissues were semi-quantitatively scored from 0 (no staining), 1 (weak staining), 2 (moderate staining) to 3 (highly intense staining) by two individual investigators. Intestinal tissue of infants with volvulus was used as a control as other intestinal tissue without major inflammation was not available. Both applied antibodies against OLFM4 showed different staining patterns with higher staining intensity of the antibody OLFM4 (D1E4M). OLFM4 (median score of the antibody OLFM4 (D1E4M): 3.0) and lysozyme (median score: 3.0) are highly expressed in intestinal and immune cells during NEC. Expression of OLFM4 and lysozyme in the control samples with volvulus was observable but significantly lower (median score of the antibody OLFM4 (D1E4M): 1.25; median score of the antibody against LYZ: 2.0; p = 0.033 and p = 0.037, respectively). Both proteins, OLFM4 and lysozyme, may play a role in the pathogenesis of NEC in neonatal patients, but the exact mechanisms of OLFM4 and lysozyme function and their role in immunological responses have not yet been resolved in detail. These observations add new insights as basis for further large-scale population research.
- Open Access
- 6 January 2022
- Published by Springer Nature in Molecular and Cellular Pediatrics
- Vol. 9 (1) , 1-10
DMBT1 expression and neutrophil-to-lymphocyte ratio during necrotizing enterocolitis are influenced by impaired perfusion due to cardiac anomalies
Background: Deleted in malignant brain tumors 1 (DMBT1) is involved in innate immunity and epithelial differentiation. It has been proven to play a role in various states of inflammation or hypoxia of fetal gastrointestinal and pulmonary diseases. Discrimination of pathogenesis in necrotizing enterocolitis (NEC) based on cardiac status improves the understanding of NEC in different patient subgroups. We aimed at examining DMBT1 expressions regarding their association with cardiac status leading to impaired intestinal perfusion, intraoperative bacteria proof, and a fulminant course of NEC. Methods: Twenty-eight patients with NEC were treated surgically between 2010 and 2019 at our institution. DMBT1 expression was examined in intestinal sections using immunohistochemistry to detect DMBT1 protein. Associations of clinical parameters and DMBT1 expression were analyzed. Results: We examined DMBT1 levels in 10 patients without cardiac defects and 18 patients with persisting ductus arteriosus (PDA) and congenital heart defects (CHD). Compared to patients without cardiac malformations, DMBT1 levels tended to score higher in patients with PDA/CHD (p = 0.2113) and were negatively correlated with C-reactive protein in these infants (p = 0.0172; r = − 0.5533). The number of DMBT1-expressing macrophages was elevated in the PDA/CHD-subgroup (p = 0.0399). Ratios of neutrophils and monocytes to lymphocytes were significantly higher in infants with PDA/CHD (p = 0.0319 and 0.0493). DMBT1 expression was significantly associated with positive bacterial culture of intraoperative swabs (p = 0.0252) and DMBT1 expression of the serosa was associated with a fulminant course of NEC (p = 0.0239). Conclusions: This study demonstrates that DMBT1 expression may be influenced by cardiac anomalies with an impaired intestinal perfusion in the neonatal intestine. NEC in PDA/CHD infants is associated with more DMBT1-positive macrophages and a significantly elevated neutrophil-to-lymphocyte ratio.
- 6 January 2022
- Published by Springer Nature in Molecular and Cellular Pediatrics
- Vol. 9 (1) , 1-10
Open AccessDMBT1 expression and neutrophil-to-lymphocyte ratio during necrotizing enterocolitis are influenced by impaired perfusion due to cardiac anomalies
Background: Deleted in malignant brain tumors 1 (DMBT1) is involved in innate immunity and epithelial differentiation. It has been proven to play a role in various states of inflammation or hypoxia of fetal gastrointestinal and pulmonary diseases. Discrimination of pathogenesis in necrotizing enterocolitis (NEC) based on cardiac status improves the understanding of NEC in different patient subgroups. We aimed at examining DMBT1 expressions regarding their association with cardiac status leading to impaired intestinal perfusion, intraoperative bacteria proof, and a fulminant course of NEC. Methods: Twenty-eight patients with NEC were treated surgically between 2010 and 2019 at our institution. DMBT1 expression was examined in intestinal sections using immunohistochemistry to detect DMBT1 protein. Associations of clinical parameters and DMBT1 expression were analyzed. Results: We examined DMBT1 levels in 10 patients without cardiac defects and 18 patients with persisting ductus arteriosus (PDA) and congenital heart defects (CHD). Compared to patients without cardiac malformations, DMBT1 levels tended to score higher in patients with PDA/CHD (p = 0.2113) and were negatively correlated with C-reactive protein in these infants (p = 0.0172; r = − 0.5533). The number of DMBT1-expressing macrophages was elevated in the PDA/CHD-subgroup (p = 0.0399). Ratios of neutrophils and monocytes to lymphocytes were significantly higher in infants with PDA/CHD (p = 0.0319 and 0.0493). DMBT1 expression was significantly associated with positive bacterial culture of intraoperative swabs (p = 0.0252) and DMBT1 expression of the serosa was associated with a fulminant course of NEC (p = 0.0239). Conclusions: This study demonstrates that DMBT1 expression may be influenced by cardiac anomalies with an impaired intestinal perfusion in the neonatal intestine. NEC in PDA/CHD infants is associated with more DMBT1-positive macrophages and a significantly elevated neutrophil-to-lymphocyte ratio.
- 1 October 2017
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 52 (10) , 1583-1590
Does an external chest wall measurement correlate with a CT-based measurement in patients with chest wall deformities?
- 1 October 2017
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 52 (10) , 1583-1590
Does an external chest wall measurement correlate with a CT-based measurement in patients with chest wall deformities?